BioCentury
ARTICLE | Clinical News

eTag: Pilot trial data

November 8, 2004 8:00 AM UTC

In a Japanese pilot study in 13 patients with breast cancer, eTag correctly differentiated responders from non-responders to Herceptin treatment. Herceptin is marketed by Genentech Inc. (DNA, South ...